...
首页> 外文期刊>Medical science monitor : >Changes in bacterial resistance patterns in children with urinary tract infections on antimicrobial prophylaxis at University Hospital in Split
【24h】

Changes in bacterial resistance patterns in children with urinary tract infections on antimicrobial prophylaxis at University Hospital in Split

机译:斯普利特大学医院抗菌药物预防尿路感染患儿细菌耐药模式的变化

获取原文
           

摘要

Background:We assessed prevalence and resistance of uropathogens on antimicrobial agents (AA) from urine cultures (UC) in children hospitalized with urinary tract infections (UTI) at University Hospital in Split.Material/Methods:During the 7-year period, children hospitalized only once with UTI alone were compared to those repeatedly hospitalized, and who received long-term antimicrobial prophylaxis (LTAP), as well as those with associated anomalies of the urinary system (US).Results:E. coli was the most frequent isolate (67.7%) with resistance to ampicillin by 69.5%, amoxicillin/clavulonic acid by 3.5%, cephalexin by 6.6%, trimethoprim/sulfamethoxazole (TMP-SMX) by 27.5%, and nitrofurantoin by 0.4%. For other uropathogens, AA resistance rates were the following: 64.3%, 5.8%, 10.5%, 21.3%, and 7.9%. The high or increasing resistance to TMP-SMX is characterized by all uropathogens. Patients with anomalies of US showed a lower prevalence of E. coli and Enterococcus sp., but a higher prevalence of Pseudomonas sp., ESBL-producing E. coli and Klebsiella sp. than those without US anomalies. Repeatedly hospitalized patients showed a lower prevalence of E. coli, but a higher prevalence of Pseudomonas sp. and Klebsiella sp. than patients hospitalized only once. Both groups displayed significantly less resistance of Enterococcus sp. In patients receiving LTAP before hospitalization, E. coli was significantly more resistant to ampicillin, amoxicillin/clavulonic acid and TMP/SMX than in those without LTAP.Conclusions:Based on our results, we recommend excluding ampicillin altogether, and reconsideration of further use of TMP-SMX, as well as use of nitrofurantoin, cephalexin and amoxicillin/clavulonic acid for LTAP in our region.
机译:背景:我们评估了在斯普利特大学医院住院的尿路感染(UTI)儿童尿液培养物(UC)上尿路致病菌对抗菌剂(AA)的流行和耐药性。材料/方法:在7年期间,住院儿童结果:E.仅将一次单独使用UTI的患者与反复住院,接受长期抗菌药物治疗(LTAP)以及泌尿系统相关异常患者(US)进行了比较。大肠杆菌是最常见的分离株(67.7%),对氨苄青霉素的耐药率为69.5%,对阿莫西林/克拉维酸的耐药率为3.5%,对头孢氨苄的耐药率为6.6%,对甲氧苄啶/磺胺甲恶唑(TMP-SMX)的耐药率为27.5%,对硝基呋喃妥因的耐药率为0.4%。对于其他尿路致病菌,AA耐药率如下:64.3%,5.8%,10.5%,21.3%和7.9%。对TMP-SMX的高耐药性或耐药性是所有尿路致病菌的特征。 US异常患者的大肠杆菌和肠球菌属菌种患病率较低,但假单胞菌属,产ESBL的大肠杆菌和克雷伯菌属菌种的患病率较高。比那些没有美国异常的人反复住院的患者显示大肠杆菌的患病率较低,但假单胞菌sp。的患病率较高。和克雷伯氏菌比只住院一次的患者。两组均显示肠球菌的抵抗力明显降低。在住院前接受LTAP的患者中,与未使用LTAP的患者相比,大肠杆菌对氨苄西林,阿莫西林/克拉维酸和TMP / SMX的抵抗力明显更高。 TMP-SMX,以及硝基呋喃妥因,头孢氨苄和阿莫西林/克拉维酸在本地区的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号